GemPharmatech Co., Ltd. (SHA:688046)

China · Delayed Price · Currency is CNY

37.94

+2.96 (8.46%)

At close: Sep 30, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Commercial Mouse Model Sales	438.77M	-				152.60M	-	-
Functional Efficacy Business	200.19M	-				32.01M	-	-
Model Creation Business	47.48M	-				24.17M	-	-
Custom Breeding Business	83.99M	-				50.06M	-	-
Agent Import and Export and Others	22.24M	-				1.62M	-	-
Unallocated Other Operations	723.07K	-				1.47M	-	-
Biotechnology	-	-				-	192.72M	53.29M
Total	793.39M	-				261.92M	192.72M	53.29M

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	640.78M	-				-	-	-
Overseas	151.88M	-				-	2.98M	726.40K
East China	-	-				-	108.85M	27.63M
Central China Region	-	-				-	10.05M	1.96M
North China	-	-				-	26.03M	10.19M
Southern China	-	-				-	28.42M	9.65M
Northwestern Region	-	-				-	1.40M	403.50K
Southwest Region	-	-				-	10.82M	2.21M
Northeast China Region	-	-				-	2.42M	522.40K
Total	792.67M	-				-	190.98M	53.29M